A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
Authors
Keywords
-
Journal
Drugs in research & development
Volume 19, Issue 4, Pages 311-318
Publisher
Springer Science and Business Media LLC
Online
2019-11-15
DOI
10.1007/s40268-019-00288-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
- (2019) D.S. Bakker et al. BRITISH JOURNAL OF DERMATOLOGY
- Letter regarding “Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab—clinical characteristics and treatment”
- (2019) Manuel Jorge Rial et al. Journal of Allergy and Clinical Immunology-In Practice
- Development of conjunctivitis with a conjunctival proliferative lesion in a patient treated with dupilumab for atopic dermatitis
- (2019) Ken Fukuda et al. ALLERGOLOGY INTERNATIONAL
- Conjunctivitis in dupilumab clinical trials
- (2019) B. Akinlade et al. BRITISH JOURNAL OF DERMATOLOGY
- Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
- (2019) J.P. Thyssen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ocular Co-Morbidities of Atopic Dermatitis. Part II: Ocular Disease Secondary to Treatments
- (2019) Kristen M. Beck et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?
- (2018) J.P. Thyssen BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
- (2018) M. de Bruin-Weller et al. BRITISH JOURNAL OF DERMATOLOGY
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
- (2018) Andreas Wollenberg et al. Journal of Allergy and Clinical Immunology-In Practice
- Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis
- (2018) Alison D. Treister et al. JAMA Dermatology
- Dupilumab-Induced Follicular Conjunctivitis
- (2018) Elizabeth Shen et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management
- (2018) Russell M. Levine et al. JAMA Dermatology
- Diagnosis and Management of Conjunctivitis for the Dermatologist
- (2017) Melinda Gooderham et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis
- (2017) Jacob P. Thyssen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Late breaking abstracts
- (2017) United European Gastroenterology Journal
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
- (2016) Claus Bachert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
- (2016) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
- (2016) Diamant Thaçi et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conjunctivitis
- (2013) Amir A. Azari et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started